血液构造细胞衍生的外体在癌症发育和治疗方面:从基础科学到临床实践
Wen-Chun Lin1, You-Tong Lin1, Hui-Ching Chao1
1Department of Biotechnology and Laboratory Science in Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Clinical and translational medicine
|October 13, 2023
概括
血造细胞衍生的外体调节瘤微环境 (TME) 并影响癌症免疫力. 本综述探讨了它们的治疗潜力和开发基于外体细胞的癌症治疗的挑战.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 纳米医学是一种纳米医学.
背景情况:
- 瘤微环境 (TME) 对癌症的发展和治疗耐药性至关重要.
- "冷"的TME,以免疫抑制为特征,与不良的临床结果有关.
- 在TME内的免疫细胞显著影响癌症的进展.
研究的目的:
- 审查血液细胞分泌的外体在调节TME和抗瘤免疫中的作用.
- 要突出目前的挑战和潜在的解决方案,以外体基的癌症疗法.
主要方法:
- 在TME中对外体功能进行文献综述.
- 对外体介导细胞间通信的分析.
- 检查涉及外体的治疗策略.
主要成果:
- 来自造血细胞的外基因组可以重新编程受体细胞并调节TME.
- 这些外体可以根据背景促进或抑制癌症的进展.
- 基于外体的疗法为个性化癌症治疗提供了一个有希望的途径.
结论:
- 造血细胞衍生的外体是TME和抗瘤免疫的关键调节者.
- 开发基于外体的疗法在生产,净化,储存和输送方面面临着挑战.
- 目前正在进行的临床试验正在评估治疗外体 (tExos) 的安全性和有效性.
相关概念视频
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Mesenchymal Stem Cells
4.8K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.8K
Stem Cell Therapy for Tissue Regeneration
4.1K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K


